Thursday, July 3, 2025 7/3/2025

Cell-Types Specific Neuroadaptations in the Nucleus Accumbens Shell Associated with Individual Differences in Cocaine-Seeking

Award Number: K01DA053434
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP
PERIOD OF PERFORMANCE START DATE: 09/30/2021
PERIOD OF PERFORMANCE END DATE: 01/31/2026

Group Awards By:

View Award Description

Cell-Types Specific Neuroadaptations in the Nucleus Accumbens Shell Associated with Individual Differences in Cocaine-Seeking - Project Summary/Abstract Although cocaine is powerfully rewarding, not all people who are exposed to this drug are equally prone to abusing it. The reasons for these differences remain unknown but may involve predisposing factors whose elucidation could lead to therapies that, in the future, may prevent cocaine addiction. One such predisposing factor is behavioral sensitivity to the aversive attributes of cocaine, which overlap with the rewarding effects to protect against cocaine-seeking. Preliminary data in this proposal suggest that the aversive effect of cocaine may be much stronger in some individuals than others and potentially a determinant for cocaine addiction vulnerability. The underlying cellular mechanism of this variability remains unknown. However, our preliminary data revealed that higher RhoA activity and D2-MSN excitability in the mNACshell correlate with rats displaying higher aversive effects of cocaine (and consequently lower drive to seek cocaine). Nevertheless, it is unknown if these cellular and molecular adaptations in the mNACshell are involved in the aversive attributes of cocaine. Accordingly, to address this gap in knowledge, I’m proposing two aims. In aim 1, I will determine the roles of D2MSN on cocaine avoidance behavior, and for this, I will be trained in fiber photometric and optogenetic methods. I hypothesize that D2- but not D1-MSNs are activated during cocaine’s aversive phase, and that D2 activity in turn drives conditioned negative attributes of cocaine. In aim 2, I will examine the roles of RhoA and related genes on neural excitability and cocaine avoidance in a cell-specific manner. First, I will use mRNA TRAP methods to analyze cell-specific gene translation associated with RhoA signaling or excitability linked to cocaine avoidance phenotypes. In addition, to test the causal role of RhoA in excitability and cocaine avoidance behavior, I will decrease or increase RhoA activity in a cell-specific manner using an adeno-associated gene manipulation strategy. I hypothesize that increases in RhoA activity in D2-MSN but not D1-MSN enhances excitability in the mNACshell confer protection against the acquisition of cocaine-seeking. An intense and comprehensive training, mentoring, and research plan has been developed to achieve these goals. This plan will be guided by a powerful team of mentors and collaborators that will help blend my current skill set with new conceptual and technical frameworks as I continue to establish my own unique and innovative research program in addiction neuroscience.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $196,934 )
2025	2025	SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE	801 N RUTLEGE	SPRINGFIELD	IL	62794	SANGAMON	USA	Drug Use and Addiction Research Programs	005	5	4/8/2025	NON-COMPETING CONTINUATION	$196,934
2025	2024	SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE	801 N RUTLEGE	SPRINGFIELD	IL	62794	SANGAMON	USA	Drug Use and Addiction Research Programs	004	4	2/26/2025	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$233,661
2025	2024	SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE	801 N RUTLEGE	SPRINGFIELD	IL	62794	SANGAMON	USA	Drug Use and Addiction Research Programs	001	4	2/14/2025	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$196,934
2025	2024	SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE	801 N RUTLEGE	SPRINGFIELD	IL	62794	SANGAMON	USA	Drug Use and Addiction Research Programs	000	4	2/13/2025	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	-$196,934
2025	2023	THE MEDICAL UNIVERSITY OF SOUTH CAROLINA	179 ASHLEY AVE	CHARLESTON	SC	29425	CHARLESTON	USA	Drug Use and Addiction Research Programs	003	3	2/26/2025	NON-COMPETING CONTINUATION	-$193,482
2025	2022	THE MEDICAL UNIVERSITY OF SOUTH CAROLINA	179 ASHLEY AVE	CHARLESTON	SC	29425	CHARLESTON	USA	Drug Use and Addiction Research Programs	002	2	2/26/2025	NON-COMPETING CONTINUATION	-$40,179
														Subtotal = $196,934

Issue Date FY: 2024 ( Subtotal = $196,934 )
2024	2024	SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE	801 N RUTLEGE	SPRINGFIELD	IL	62794	SANGAMON	USA	Drug Use and Addiction Research Programs	001	4	8/30/2024	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$196,934
2024	2023	THE MEDICAL UNIVERSITY OF SOUTH CAROLINA	179 ASHLEY AVE	CHARLESTON	SC	29425	CHARLESTON	USA	Drug Use and Addiction Research Programs	000	3	8/30/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $196,934

Issue Date FY: 2023 ( Subtotal = $193,482 )
2023	2023	MEDICAL UNIVERSITY OF SOUTH CAROLINA THE	179 ASHLEY AVE	CHARLESTON	SC	29425	CHARLESTON	USA	Drug Use and Addiction Research Programs	000	3	8/2/2023	NON-COMPETING CONTINUATION	$193,482
														Subtotal = $193,482

Issue Date FY: 2022 ( Subtotal = $193,482 )
2022	2022	MEDICAL UNIVERSITY OF SOUTH CAROLINA THE	179 ASHLEY AVE	CHARLESTON	SC	29425	CHARLESTON	USA	Drug Use and Addiction Research Programs	001	2	8/1/2022	NON-COMPETING CONTINUATION	$193,482
2022	2021	MEDICAL UNIVERSITY OF SOUTH CAROLINA THE	179 ASHLEY AVE	CHARLESTON	SC	29425	CHARLESTON	USA	Drug Use and Addiction Research Programs	000	1	4/1/2022	NEW	$0
														Subtotal = $193,482

Issue Date FY: 2021 ( Subtotal = $193,482 )
2021	2021	MEDICAL UNIVERSITY OF SOUTH CAROLINA THE	179 ASHLEY AVE	CHARLESTON	SC	29425	CHARLESTON	USA	Drug Use and Addiction Research Programs	000	1	9/22/2021	NEW	$193,482
														Subtotal = $193,482

Grand Total All Awards = $974,314

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Cell-Types Specific Neuroadaptations in the Nucleus Accumbens Shell Associated with Individual Differences in Cocaine-Seeking

Award Number: K01DA053434

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

PERIOD OF PERFORMANCE START DATE: 09/30/2021

PERIOD OF PERFORMANCE END DATE: 01/31/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer